| Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial. | |
MedLine Citation:
|
PMID: 23616386 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVES/HYPOTHESIS: To investigate how quickly an allergic rhinitis (AR) patients' symptoms will improve with sublingual immunotherapy (SLIT). STUDY DESIGN: Double-blind placebo study. METHODS: This is a multicenter, randomized, double-blind, placebo-controlled study of SLIT used to treat house dust mite-induced AR. A total of 120 AR patients, aged 4 to 60 years, were treated for 6 months and randomized into two groups: 1) SLIT with Dermatophagoides pteronyssinus (D.p.) and Dermatophagoides farina (D.f.) extract (n = 60) ; and 2) matched placebo controls (n = 60). Symptom, medications received, and a visual analog scale score were recorded during the whole study. Serum-specific IgE and IgG4 to D. p. and D. f. were assessed before and after the treatment. RESULTS: Eighty-five patients (70.8%) completed the study. Twelve patients (20%) chose to withdraw from the SLIT group, but none because of serious adverse effects. The total symptom and visual analog scores VAS in the SLIT group decreased significantly when compared to the placebo controls (P <0.05) after week 14, as well as for the significant (P <0.05) improvement of all individual AR symptoms in the SLIT group (e.g., sneezing, nasal discharge, itching, and nasal obstruction) after week 22. There was a significant (P <0.05) increase of IgG4 to both D.f. and D.p. in the SLIT, but not in the placebo group after treatment. CONCLUSION: SLIT with a mixture of D.f. and D.p. extract is an effective and safe treatment for patients with house dust mite-induced AR. Its onset of action can be observed as early as 14 weeks after treatment. LEVEL OF EVIDENCE: 1B. Laryngoscope, 2012. |
Authors:
|
De-Hui Wang; Lei Chen; Lei Cheng; Ke-Nan Li; Hu Yuan; Ji-Hong Lu; Han Li |
Related Documents
:
|
12165366 - Spect imaging, clinical features, and cognition before and after low doses of amisulpri... 17999256 - Clinical implications of the catie schizophrenia trials: day-to-day management lessons ... 23616386 - Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rh... 19011586 - Ten year outcome of tardive dyskinesia during continuous treatment with first generatio... 22668246 - Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-w... 15465396 - Smell testing is abnormal in 'lubag' or x-linked dystonia-parkinsonism: a pilot study. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-4-24 |
Journal Detail:
|
Title: The Laryngoscope Volume: - ISSN: 1531-4995 ISO Abbreviation: Laryngoscope Publication Date: 2013 Apr |
Date Detail:
|
Created Date: 2013-4-25 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8607378 Medline TA: Laryngoscope Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 The American Laryngological, Rhinological and Otological Society, Inc. |
Affiliation:
|
Department of Otolaryngology, Eye & ENT Hospital, Fudan University, Shanghai. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Self-Delivery Multifunctional Anti-HIV Hydrogels for Sustained Release.
Next Document: Click To Bind: Metal Sensors.